W Health Ventures Launches $100 Million Second Fund

Rapid Summary

• Bengaluru-based W Health Ventures, founded by Sunil Wadhwani, has launched its second healthcare-focused fund targeting $70 million (Rs 600 crore) with a hard cap of $100 million (Rs 850 crore).
• This venture capital firm, operating in Boston and India, plans to announce the fundS first close this quarter.
• Fund II aims to build and scale eight to ten healthcare companies over the next four years while supporting existing platforms.
• The firm’s portfolio from Fund I reportedly impacted over 25 million patients globally.
• Initial investments for Fund II include:

– Everhope Oncology: A $10 million joint venture with Narayana Health focusing on cancer care in India through advanced diagnostics, therapies, and decentralized treatment centers.
– A US-based psychiatric managed services platform currently operating in stealth mode.

• Leadership expansion includes four new senior operating partners specializing in offline healthcare operations, AI-enabled services, and global market strategies for US businesses.
• Core strategies: Single-specialty care delivery platforms tailored for Indian needs and AI-enabled cross-border B2B healthcare solutions leveraging India’s clinical expertise.
• Healthcare has been identified as one of the strongest-performing investment categories in India.

!W Health Ventures team

Read more

Indian Opinion Analysis

W Health Ventures’ launch of a second fund targeting up to $100 million signals strong investor confidence in india’s rapidly evolving healthcare sector. The firm’s dual focus-on innovation within India’s single-specialty care segment and leveraging AI-powered services for global markets-reflects strategic alignment with industry trends where technology-driven models are reshaping patient outcomes.

The planned investments underscore specific gaps such as cancer care infrastructure via Everhope Oncology’s decentralised centers and improved psychiatric services internationally through U.S.-based projects. By integrating clinical expertise with engineering talent from India into scalable platforms globally, this approach could fuel robust cross-border collaboration.healthcare continues to be a promising investment category due to growing demand both within domestic markets still dominated by offline engagements (as noted by Jethwani) and abroad where efficiency-driven digital transformation offers untapped opportunities. However,it remains crucial how effective this “company creation” model will be sustainable long-term while bridging India’s lag relative to international benchmarks mentioned explicitly (10-15 years gap).